anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
atai Life Sciences · conference-presentation

ATAI | Investor Day Presentation Deck | 42 slides

42 pages · 3 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

ATAI | Investor Day Presentation Deck | 42 slides

atai Life Sciences · 2022-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON
Narrative range 16 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 6 slides 100% 6/6 slides 100% 6/6 slides · 26 hits
— 0/6 slides
50% 3/6 slides 16.7% 1/6 slides 100% 6/6 slides 83.3% 5/6 slides Agitate (Make it worse) 2 slides 100% 2/2 slides 100% 2/2 slides · 10 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides
— 0/2 slides
Solution (Provide relief) 8 slides 100% 8/8 slides 100% 8/8 slides · 30 hits
— 0/8 slides
62.5% 5/8 slides 12.5% 1/8 slides 100% 8/8 slides 25% 2/8 slides

Slide inventory

42
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
front_matter
Open slide detail
03
front_matter
Open slide detail
04
The slide uses a numbered list format to highlight key strategic pillars.summarize
Open slide detail
05
Includes a highlighted row for RL-007 and a section for equity interests.analyze_data
Open slide detail
06
introduce_nominees
Open slide detail
07
front_matter
Open slide detail
08
other
Open slide detail
09
establish_context
Open slide detailBeat · Problem (Identify pain)
10
The slide uses icons to represent three key negative outcomes for the patient population.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
11
The slide uses a citation to support the data.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
12
Data source: Keefe et al, Schiz Res, 2011.analyze_data
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
13
The slide uses a causal chain diagram to link neurocognitive deficits to functional outcomes and a bar chart to show correlation strength.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
14
The chart uses a broken y-axis between 35 and 100 to accommodate the data distribution.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
15
The slide uses a comparative analysis between cancer and schizophrenia/CIAS to highlight resource allocation disparities.diagnose_problem
Open slide detailBeat · Agitate (Make it worse)
16
establish_context
Open slide detailBeat · Agitate (Make it worse)
17
The slide contrasts specific receptor-targeted programs with a more complex multi-receptor approach.summarize
Open slide detail
18
The chart displays statistical significance markers (*) for specific time points and treatment groups.analyze_data
Open slide detail
19
transition
Open slide detail
20
introduce_nominees
Open slide detail
21
establish_context
Open slide detailBeat · Solution (Provide relief)Loop · Aha Moment
22
frame_situation
Open slide detailBeat · Solution (Provide relief)Loop · Aha Moment
23
The slide uses a process flow to map research/clinical stages to specific de-risking milestones.present_framework
Open slide detailBeat · Solution (Provide relief)
24
summarize
Open slide detailBeat · Solution (Provide relief)
25
The slide includes a time-series line chart showing fEPSP slope over time and a bar chart showing fEPSP amplitude changes across different treatment conditions.analyze_data
Open slide detailBeat · Solution (Provide relief)
26
summarize
Open slide detailBeat · Solution (Provide relief)
27
frame_problem
Open slide detailBeat · Solution (Provide relief)
28
The table maps study types (HV PK, Scopolamine, Peripheral Diabetic Neuropathy) against Phase 1/2 status and key clinical endpoints (Safety/PK, Target Engaged, summarize
Open slide detailBeat · Solution (Provide relief)
29
The slide uses red dashed boxes to highlight the 40mg dose performance in both single and 7-day TID dosing scenarios.analyze_data
Open slide detail
30
Includes EEG brain mapping, cognitive test results (Continuity of Attention, Delayed Word Recall), and DPNP study data.summarize
Open slide detail
31
summarize
Open slide detail
32
summarize
Open slide detail
33
The slide outlines a clinical trial design including screening, in-patient dosing, and follow-up phases.present_framework
Open slide detail
34
The table uses directional arrows to indicate the direction of change in qEEG endpoints across different cohorts and brain regions (F, C, T, P, O).analyze_data
Open slide detail
35
The slide presents clinical trial data comparing ERP responses (MMN and P300b) across different dose levels of RL-007.summarize
Open slide detail
36
The slide includes a visual representation of the BACS symbol coding test.present_framework
Open slide detail
37
The chart highlights a non-linear dose-response relationship where 40mg appears to be the peak efficacy point across the measured tasks.analyze_data
Open slide detail
38
CIAS stands for Cognitive Impairment Associated with Schizophrenia.summarize
Open slide detail
39
Includes a quote from Keith Nuechterlein regarding the clinical significance of the symbol coding results.summarize
Open slide detail
40
The table maps study types against phases and outcomes (Safety/PK, Target Engaged, Biphasic).plan_implementation
Open slide detail
41
summarize
Open slide detail
42
filler
Open slide detail